Elina Tripoliti

Speech and Deep Brain Stimulation in Parkinson's Disease, Essential Tremor, and Dystonia: A Systematic Review and Meta‐analysis

Elina Tripoliti, Takashi Tsuboi, Michael T. Barbe, Mario Sousa et autres

Deep brain stimulation (DBS) effectively treats motor symptoms in movement disorders but often compromises speech through incompletely defined mechanisms. We conducted a PROSPERO-registered systematic review and meta-analysis of publications through August 2024 (CRD42024527738). Among 2726 screened records, we included 184 studies: 131 …

gr, gb, jp, de, ch, us, cz (code pays fourni par la source)

Speech and Deep Brain Stimulation in Parkinson's Disease, Essential Tremor, and Dystonia: A Systematic Review and Meta-analysis.

Elina Tripoliti, Takashi Tsuboi, Michael T. Barbe, Mario Sousa et autres

Deep brain stimulation (DBS) effectively treats motor symptoms in movement disorders but often compromises speech through incompletely defined mechanisms. We conducted a PROSPERO-registered systematic review and meta-analysis of publications through August 2024 (CRD42024527738). Among 2726 screened records, we included 184 studies: 131 …

at (code pays fourni par la source)

Is thalamic deep brain stimulation the right target to improve laryngeal dystonia symptoms?

Lena C. O’Flynn, Michael T. Barbe, Shiro Horisawa, Julie M. Barkmeier‐Kraemer et autres

Introduction Laryngeal dystonia (LD), formerly known as spasmodic dysphonia, is one of the common forms of focal dystonia characterized by involuntary spasms in the laryngeal muscles that selectively impair speech production. The current standard of care for patients with LD is symptom …

us, de, jp, ca, cz, gr, gb (code pays fourni par la source)

Stuttering and Dystonia: Is There a Possible Overlap?

Shermyn Neo, Elina Tripoliti, Elie Matar, Bettina Balint et autres

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Table S1. Comparison of stuttering and dystonia. Table S2. Suggested protocol for speech …

sg, gr, gb, au, ch (code pays fourni par la source)

From prodromal stages to clinical trials: The promise of digital speech biomarkers in Parkinson's disease

Jan Rusz, Paul Krack, Elina Tripoliti

Speech impairment is a common and disabling symptom in Parkinson's disease (PD), affecting communication and quality of life. Advances in digital speech processing and artificial intelligence have revolutionized objective speech analysis. Given the complex nature of speech impairment, acoustic speech analysis offers …

cz, ch, gb (code pays fourni par la source)

Which aspects of motor speech disorder are captured by Mel Frequency Cepstral Coefficients? Evidence from the change in STN-DBS conditions in Parkinson’s disease

Vojtěch Illner, Petr Krýže, Jan Švihlík, Mário Sousa et autres

One of the most popular speech parametrizations for dysarthria has been Mel Frequency Cepstral Coefficients (MFCCs). Although the MFCCs ability to capture vocal tract characteristics is known, the reflected dysarthria aspects are primarily undisclosed. Thus, we investigated the relationship between key acoustic …

Relationship between LTAS-based spectral moments and acoustic parameters of hypokinetic dysarthria in Parkinson’s disease

Jan Švihlík, Vojtěch Illner, Petr Krýže, Mário Sousa et autres

Although long-term averaged spectrum (LTAS) descriptors can detect the change in dysarthria of patients with Parkinson's disease (PD) due to subthalamic nucleus deep brain stimulation (STN-DBS), the relationship between LTAS variables with measures that relate to laryngeal physiology remain unknown. We aimed …

Electrical stimulation in deep brain structures and its impact on speech for patients with Parkinson’s disease: opportunities and challenges

Elina Tripoliti

Speech outcome following deep brain stimulation: a bilateral interdisciplinary challenge between speech/neuro-sciences and clinical assessment/management Symposium description: Neurostimulation has become an effective treatment option for patients with movement disorders, as well as for other pathologies.However, a frequent worsening of speech can occur …

gb (code pays fourni par la source)

Neural bases of speech production and speech impairment in movement disorders: for a better understanding of speech outcome following deep brain stimulation

Serge Pinto, Marie‐Charlotte Cuartero, Michael T. Barbe, Elina Tripoliti

Symposium title: Speech outcome following deep brain stimulation: a bilateral interdisciplinary challenge between speech/neuro-sciences and clinical assessment/management Symposium description: Neurostimulation has become an effective treatment option for patients with movement disorders, as well as for other pathologies. However, a frequent worsening of …

fr, de, gb (code pays fourni par la source)

Long-Term Averaged Spectrum Descriptors of Dysarthria in Patients With Parkinson's Disease Treated With Subthalamic Nucleus Deep Brain Stimulation

Jan Švihlík, Michal Novotný, Tereza Tykalová, Kamila Poláková et autres

Purpose: This study aimed to evaluate whether long-term averaged spectrum (LTAS) descriptors for reading and monologue are suitable to detect worsening of dysarthria in patients with Parkinson's disease (PD) treated with subthalamic nucleus deep brain stimulation (STN-DBS) with potential effect of ON …

us, cz, ch, gb (code pays fourni par la source)

Elektrische Stimulation tiefer Hirnstrukturen: Auswirkungen auf das Sprechen

Elina Tripoliti, Lorraine A. Ramig

Die elektrische Stimulation tiefer Hirnstrukturen kann bei Parkinson-Patienten zu einer Verschlechterung des Sprechens und der Stimme führen. Dabei sind die Auswirkungen individuell unterschiedlich und von anatomisch, klinisch-therapeutischen und neurochirurgischen Faktoren abhängig. Teamarbeit zwischen den Berufsgruppen Neurochirurgie/ Neurologie und Sprachtherapie ist notwendig, um …

Evidenzbasierte Sprachtherapie bei Morbus Parkinson: LSVT LOUD

Angela E. Halpern, Cynthia Fox, Lorraine A. Ramig, Elina Tripoliti

Die meisten Patient*innen mit Morbus Parkinson entwickeln im Laufe ihrer Erkrankung Stimm- und Sprechstörungen. Die Wirksamkeit des Stimm- und Sprechtherapieverfahrens LSVT LOUD ist hier nachgewiesen. Auch sollte bereits vor neurochirurgischer Therapie mittels tiefer Hirnstimulation im Bereich des Nucleus subthalamicus eine LSVT-LOUD-Therapie durchgeführt …